Search results
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 9 hours agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst - Legend...
Benzinga· 13 hours agoShares of cell therapy company Legend Biotech Corp LEGN were trading lower on Monday, after being...
Gateway - Quartz
Quartz· 30 minutes agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves. AstraZeneca announced ...
Previously Unknown Immune System Link Uncovered – Findings Could Lead to New Cancer Treatments
SciTechDaily· 17 hours agoWeill Cornell scientists discovered a crucial link between two immune pathways involving IL-23 and...
What do we know about Kate's cancer treatment?
BBC via AOL· 3 days ago[Getty Images] Catherine, Princess of Wales, says she is still having preventative chemotherapy for cancer which was found after major abdominal surgery...
LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial
Clinical Trials Arena via Yahoo Finance· 4 days ago"LG Chem and AVEO Oncology enrol first subject in Phase I anti-cancer drug trial" was originally...
Health Care Roundup: Market Talk
The Wall Street Journal· 8 hours agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1054 ET...
OpenAI Expands Healthcare Push With Color Health’s Cancer Copilot
The Wall Street Journal· 18 hours agoThat involves comparing a retrospective analysis against a prospective trial, he said, while...
Video: Improvements in prostate surgery
Medical Xpress· 11 hours agoThere will be approximately 299,010 new cases of prostate cancer diagnosed in 2024, according to the American Cancer Society. Treatments vary, including ...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 4 days agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...
